diphenyleneiodonium and pitavastatin

diphenyleneiodonium has been researched along with pitavastatin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoguchi, T; Kobayashi, K; Nakayama, M; Nawata, H; Sasaki, S; Sato, N; Sonoda, N; Tsubouchi, H; Yu, HY	1

Other Studies

1 other study(ies) available for diphenyleneiodonium and pitavastatin

Article	Year
Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells. Medicinal chemistry (Shariqah (United Arab Emirates)), 2005, Volume: 1, Issue:5 Topics: Angiotensin II; Cells, Cultured; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesangial Cells; Mitogen-Activated Protein Kinases; NADPH Oxidases; Naphthalenes; Onium Compounds; Oxidative Stress; Quinolines; Sensitivity and Specificity; Structure-Activity Relationship	2005

Article

Year

Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells.

Medicinal chemistry (Shariqah (United Arab Emirates)), 2005, Volume: 1, Issue:5

Topics: Angiotensin II; Cells, Cultured; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesangial Cells; Mitogen-Activated Protein Kinases; NADPH Oxidases; Naphthalenes; Onium Compounds; Oxidative Stress; Quinolines; Sensitivity and Specificity; Structure-Activity Relationship

2005